Market Size of Separation Systems For Commercial Biotechnology Industry
| Study Period | 2019 - 2029 |
| Market Size (2024) | USD 24.91 Billion |
| Market Size (2029) | USD 30.51 Billion |
| CAGR (2024 - 2028) | 4.20 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Separation Systems For Commercial Biotechnology Market Analysis
The Separation Systems For Commercial Biotechnology Market size is estimated at USD 24.91 billion in 2024, and is expected to reach USD 30.51 billion by 2029, growing at a CAGR of 4.20% during the forecast period (2024-2029).
- The major factor contributing to the market's growth is the increasing advancement of cell separations and the growing demand for biopharmaceuticals. For instance, in November 2022, Sony Corporation launched the SFA - Life Sciences Cloud Platform. This flow cytometry data analysis cloud solution can quickly identify rare cells, such as cancer and stem cells, from various cell populations using data obtained from flow cytometers.
- Similarly, in September 2022, Tosoh Bioscience GmbH, a provider of chromatographic solutions for the separation and purification of biomolecules, launched the Octave BIO multi-column chromatography (MCC) system. This system, combined with the SkillPak BIO pre-packed columns, enables customers to develop pre-clinical processes quickly and efficiently. Thus, developing such innovative cloud platforms and launching various chromatography systems are expected to augment the demand for separation systems, contributing to the market growth during the forecast period.
- Moreover, research studies involving the recent advancement of cell separation are expected to drive market growth. For instance, as per the article published in January 2022 in MDPI, magnetic cell separation has emerged as a critical technology for isolating specific cell populations from biological suspensions, with applications ranging from diagnosis and therapy in biomedicine to environmental applications or fundamental research in biology. Hence, owing to the increase in advantages offered by separation systems, the market is expected to witness significant growth during the forecast period.
- Thus, due to the increase in product launches and advancements in cell separation in biotechnology, the separation systems for the commercial biotechnology market are expected to witness significant growth during the forecast period. However, the high cost of research and development will likely restrain market growth.
Separation Systems For Commercial Biotechnology Industry Segmentation
Separation systems purify biological products such as biopharmaceuticals, biochemicals, and diagnostic reagents depending on the electrostatic charge, density, diffusivity, shape, polarity, solubility, and volatility characteristics. The equipment that separates biological material from complex mixtures or solutions includes chromatography, membranes or filters, and centrifuges.
The separation systems for the commercial biotechnology market are segmented by method, application, and geography. By method, the market is segmented into modern methods and conventional methods. By application, the market is segmented as biopharmaceutical, food and cosmetics, agriculture, and other applications. By geography, the market is segmented as North America, Europe, Asia-Pacific, Middle East and Africa, and South America. The report also covers the estimated market sizes and trends for 17 countries across the major regions globally.
The report offers the value (USD) for all the above segments.
| By Methods | ||||||
| ||||||
|
| By Application | |
| Biopharmaceutical | |
| Food and Cosmetics | |
| Agriculture | |
| Other Applications |
| Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Separation Systems For Commercial Biotechnology Market Size Summary
The separation systems for commercial biotechnology market is poised for substantial growth, driven by advancements in cell separation technologies and the increasing demand for biopharmaceuticals. Innovations such as Sony Corporation's SFA - Life Sciences Cloud Platform and Tosoh Bioscience GmbH's Octave BIO multi-column chromatography system exemplify the technological progress fueling market expansion. These developments, alongside the growing application of magnetic cell separation in biomedicine and environmental research, are expected to significantly enhance the market's trajectory. However, the high costs associated with research and development may pose challenges to market growth. The biopharmaceutical sector, in particular, is anticipated to experience notable growth due to the rising demand for personalized medicines and cell-based therapies, supported by advancements in separation technologies like chromatography and membrane filtration systems.
North America is projected to maintain a significant market share, bolstered by the presence of key industry players, robust research activities, and a well-established healthcare infrastructure. Government initiatives and research funding are further expected to propel market growth in the region. The establishment of pharmaceutical companies focusing on endocrinology, such as Redesign Health's recent venture, is likely to increase the demand for separation systems. The market is moderately competitive, with major players like Perkin Elmer Inc., Sartorius AG, and Thermo Fisher Scientific Inc. actively engaging in strategic partnerships and product innovations to enhance their offerings. Recent product launches, such as Bio-Rad Laboratories Inc.'s StarBright Dyes and METAFORA Biosystems' METAflow platform, highlight the ongoing advancements in separation technologies, contributing to the market's dynamic landscape.
Separation Systems For Commercial Biotechnology Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 Advances in Cell Separation Techniques and Rising Demand for Cell-based Therapies
-
1.2.2 Rise in Government and Private Funding
-
-
1.3 Market Restraints
-
1.3.1 High Cost Involved in Research and Development
-
-
1.4 Porter's Five Forces Analysis
-
1.4.1 Threat of New Entrants
-
1.4.2 Bargaining Power of Buyers/Consumers
-
1.4.3 Bargaining Power of Suppliers
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION (Market Size by Value - USD)
-
2.1 By Methods
-
2.1.1 Mordern Methods
-
2.1.1.1 Microarray
-
2.1.1.2 Lab-on-a-chip
-
2.1.1.3 Magnetic separation
-
2.1.1.4 Other Modern Methods
-
-
2.1.2 Conventional Methods
-
2.1.2.1 Chromatography
-
2.1.2.2 Flow Cytometry
-
2.1.2.3 Membrane Filtration
-
2.1.2.4 Other Conventional Methods
-
-
-
2.2 By Application
-
2.2.1 Biopharmaceutical
-
2.2.2 Food and Cosmetics
-
2.2.3 Agriculture
-
2.2.4 Other Applications
-
-
2.3 Geography
-
2.3.1 North America
-
2.3.1.1 United States
-
2.3.1.2 Canada
-
2.3.1.3 Mexico
-
-
2.3.2 Europe
-
2.3.2.1 Germany
-
2.3.2.2 United Kingdom
-
2.3.2.3 France
-
2.3.2.4 Italy
-
2.3.2.5 Spain
-
2.3.2.6 Rest of Europe
-
-
2.3.3 Asia-Pacific
-
2.3.3.1 China
-
2.3.3.2 Japan
-
2.3.3.3 India
-
2.3.3.4 Australia
-
2.3.3.5 South Korea
-
2.3.3.6 Rest of Asia-Pacific
-
-
2.3.4 Middle East and Africa
-
2.3.4.1 GCC
-
2.3.4.2 South Africa
-
2.3.4.3 Rest of Middle East and Africa
-
-
2.3.5 South America
-
2.3.5.1 Brazil
-
2.3.5.2 Argentina
-
2.3.5.3 Rest of South America
-
-
-
Separation Systems For Commercial Biotechnology Market Size FAQs
How big is the Separation Systems For Commercial Biotechnology Market?
The Separation Systems For Commercial Biotechnology Market size is expected to reach USD 24.91 billion in 2024 and grow at a CAGR of 4.20% to reach USD 30.51 billion by 2029.
What is the current Separation Systems For Commercial Biotechnology Market size?
In 2024, the Separation Systems For Commercial Biotechnology Market size is expected to reach USD 24.91 billion.
